TLR4 inhibited autophagy by modulating PI3K/AKT/mTOR signaling pathway in Gastric cancer cell lines

被引:2
|
作者
Zhang, Qian [1 ]
Dan, Jun [2 ]
Meng, Shuang [1 ]
Li, Yingjie [1 ]
Li, Jing [1 ]
机构
[1] Jinzhou Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Jinzhou 121000, Liaoning, Peoples R China
[2] Jinzhou Med Univ, Dept Geriatr, Affiliated Hosp 1, Jinzhou 121000, Liaoning, Peoples R China
关键词
Gastric cancer; TLR4; PI3K; AKT; Autophagy; Proliferation; TOLL-LIKE RECEPTORS; EXPRESSION; TUMOR; PROMOTES; INFLAMMATION; MECHANISM; INFECTION; CARCINOMA; ADHESION; INVASION;
D O I
10.1016/j.gene.2023.147520
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Toll-like receptors (TLRs) are pattern recognition receptors found on both immune and cancerous cells. Gastric cancer (GC) cells/tissues have been shown to exhibit elevated levels of TLR4. Here, we examined the role of TLR4 on autophagy and proliferation in GC cells. Real-time quantitative polymerase chain reaction (RT-qPCR) and western blot (WB) were used to determine TLR4 levels at different stages of GC cells/tissues as well as the levels of autophagy-related proteins (ARPs) and determine the underlying signaling mechanism. Proliferation was assessed via the CCK-8 assay. The protein and mRNA levels of ARPs were elucidated, followed by estimating the involved signaling pathways. Our results demonstrated that the modulation of the PI3K/AKT/mTOR pathway resulted from autophagy inhibition/induction, which was induced by the overexpression and knockdown of TLR4. Thus, TLR4 played a vital role in GC progression.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Cadmium accelerates autophagy of osteocytes by inhibiting the PI3K/AKT/mTOR signaling pathway
    Song, Ruilong
    He, Shuangjiang
    Cao, Ying
    Lu, Yicheng
    Peng, Yunwen
    Zou, Hui
    Tong, Xishuai
    Ran, Di
    Ma, Yonggang
    Liu, Zongping
    ENVIRONMENTAL TOXICOLOGY, 2023, 38 (08) : 1980 - 1988
  • [22] Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
    Morgos, Diana-Theodora
    Stefani, Constantin
    Miricescu, Daniela
    Greabu, Maria
    Stanciu, Silviu
    Nica, Silvia
    Stanescu-Spinu, Iulia-Ioana
    Balan, Daniela Gabriela
    Balcangiu-Stroescu, Andra-Elena
    Coculescu, Elena-Claudia
    Georgescu, Dragos-Eugen
    Nica, Remus Iulian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [23] Targeting PI3K/Akt/mTOR signaling in cancer
    Porta, Camillo
    Paglino, Chiara
    Mosca, Alessandra
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [24] Diterpenoid tanshinones inhibit gastric cancer angiogenesis through the PI3K/Akt/mTOR signaling pathway
    Yu, Jie-ru
    Liu, Yu-yue
    Gao, Yang-yang
    Qian, Li-hui
    Qiu, Jia-lin
    Wang, Pei-pei
    Zhang, Guang-ji
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 324
  • [25] SERPINA5 promotes tumour cell proliferation by modulating the PI3K/AKT/mTOR signalling pathway in gastric cancer
    Fan, Meiyang
    Xiong, Xiaofan
    Han, Lin
    Zhang, Lingyu
    Gao, Shanfeng
    Liu, Liying
    Wang, Xiaofei
    Huang, Chen
    Tong, Dongdong
    Yang, Juan
    Zhao, Lingyu
    Shao, Yuan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (18) : 4837 - 4846
  • [26] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    Li, HaiXia
    Zeng, JianFang
    Shen, Keng
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (06) : 1067 - 1078
  • [27] PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
    Antonino Glaviano
    Aaron S. C. Foo
    Hiu Y. Lam
    Kenneth C. H. Yap
    William Jacot
    Robert H. Jones
    Huiyan Eng
    Madhumathy G. Nair
    Pooyan Makvandi
    Birgit Geoerger
    Matthew H. Kulke
    Richard D. Baird
    Jyothi S. Prabhu
    Daniela Carbone
    Camilla Pecoraro
    Daniel B. L. Teh
    Gautam Sethi
    Vincenzo Cavalieri
    Kevin H. Lin
    Nathalie R. Javidi-Sharifi
    Eneda Toska
    Matthew S. Davids
    Jennifer R. Brown
    Patrizia Diana
    Justin Stebbing
    David A. Fruman
    Alan P. Kumar
    Molecular Cancer, 22
  • [28] PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
    Leiphrakpam, Premila D.
    Are, Chandrakanth
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [29] The PI3K/AKT/mTOR signaling pathway: Implications in the treatment of breast cancer
    Andreopoulou E.
    Current Breast Cancer Reports, 2011, 3 (1) : 63 - 74
  • [30] The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
    Matsuoka, Tasuku
    Yashiro, Masakazu
    CANCERS, 2014, 6 (03) : 1441 - 1463